GREY:DGCRF - Post by User
Post by
Konderoon Sep 26, 2012 10:23pm
281 Views
Post# 20418534
About Previstage...
About Previstage... Diagnocure failed to sell the test by its own; its partner , Lab 21 in the United Kingdom, failed too in 2009; finally, Signal Genetics seems to follow the same rut. Those failures have in common the fact that none of them was preceded by a positive clinical study strongly validated by a second one. Cur wants to correct that deficiency with the Vitar study ( part l and part ll ).
Because that's what colorectal cancer specialists are expecting: a test with a high pronostic value , as guidance for different adapted therapies: chemotherapy, radiotherapy etc. They want indisputable results coming from scientific studies.
Fantomatus